SS
KYNB

Simplicity Solutions’s Kyntra Bio KYNB Stock Holding History

Simplicity Solutions’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-416
Closed -$317K – 295
2015
Q4 		$317K Buy
+416
New +$276K 0.04% 538

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Simplicity Solutions's KYNB Position: Q1 2016 in Review

Simplicity Solutions sold out of Kyntra Bio (KYNB) in Q1 2016, closing a stake of 416 shares — an estimated $317K sold.

Simplicity Solutions first reported a position in KYNB in Q4 2015 and held it in 1 quarter. The position peaked at $317K in Q4 2015. 134 funds tracked by Wall St. Rank hold KYNB as of Q1 2016.

  • Simplicity Solutions reported no remaining Kyntra Bio position as of Q1 2016 after selling out during the quarter.
  • Simplicity Solutions sold 416 Kyntra Bio shares in Q1 2016, an estimated $317K.
  • Simplicity Solutions first reported a position in Kyntra Bio in Q4 2015 and held it in 1 quarter.
  • Simplicity Solutions's Kyntra Bio position peaked at $317K in Q4 2015.
  • 134 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2016.

Based on Simplicity Solutions's 13F filing for Q1 2016, filed 26 Apr 2016.